Development of the spinal cord requires dynamic and tightly controlled expression of numerous transcription factors. Forkhead Box protein J1 (FoxJ1) is a transcription factor involved in ciliogenesis and is specifically expressed in ependymal cells (ECs) in the adult central nervous system. However, using FoxJ1 fate-mapping mouse lines, we observed that FoxJ1 is also transiently expressed by the progenitors of other neural subtypes during development. Moreover, using a knock-in mouse line, we discovered that FoxJ1 is essential for embryonic progenitors to follow a normal developmental trajectory. FoxJ1 loss perturbed embryonic progenitor proliferation and cell fate determination, and resulted in formation of adult ECs having impaired stem cell potential and an inability to respond to spinal cord injury in both male and female animals. Thus, our study uncovers unexpected developmental functions of FoxJ1 in cell fate determination of subsets of neural cells and suggests that FoxJ1 is critical for maintaining the stem cell potential of ECs into adulthood.
Introduction
The spinal cord comprises the caudal region of the central nervous system (CNS) and is responsible for conveying motor and sensory information between the brain and the periphery, as well as for elaborating reflexes. During development, spinal cord progenitor cells surrounding the ventricular zone, the nascent central canal, are subjected to their cell fate determination mainly by gradients of dorsal and ventral morphogens, such as BMPs, Wnt, and Shh [5] . The diffusion of these different morphogens activates or represses a number of transcription factor families, giving rise to spatially segregated progenitor domains along the dorsal-ventral axis, marked by sets of transcription factors including Olig2, Pax2, Chox10, among others [10] . These progenitor domains will later produce waves of distinct subtypes of neurons and glial cells [11, 31] , which migrate from their homeodomains of origin to their final locations in the spinal cord and engage in distinct circuits [1, 14, 2, 28, 38, 9] . We have a good understanding of neurogenesis and the type of neurons that originate from each ventricular domain during development, on the other hand our understanding of the complex developmental origin of glial cells (astrocytes, oligodendrocytes, and ependymal cells), their fate specification, and consequent heterogeneity is more limited [12, 18, 41, 8] . Several subtypes of astrocytes are generated in a similar spatial manner around the ventricular zone, and migrate horizontally into the lateral regions [15] , however gliogenesis in the dorsal spinal cord has not been studied in detail yet [12] . Ependymal cells appear around the ventricular zone at E15.5 in mice. Their differentiation is dependent on Shh signaling pathway and the expression of the transcription factor FoxJ1 [20, 38] . In contrast to newly born astrocytes, ependymal cells that appear around E15.5 do not migrate away from the central canal, as they are involved in the https://doi.org/10.1016/j.yexcr.2018.04.017 Received 12 April 2018; Accepted 15 April 2018 production and regulation of cerebrospinal fluid, remaining proliferative and continuously expressing FoxJ1 during embryonic development and throughout adulthood [20, 23] . The heterogeneity of progenitor subtypes during development is reflected in the neural cell type variety generated and present later on in adulthood [19, 36, 40, 4] .
Ependymal cells can easily be identified by FoxJ1 expression, a transcription factor classically involved in ciliogenesis and expressed by diverse multi-ciliated cells, including cells in the choroid plexus, lung epithelium, oviduct and testis [13, 25, 35, 39, 7] . Therefore, in the CNS, FoxJ1 is mostly considered a specific marker for ependymal cells. However, FoxJ1 is also expressed by subsets of progenitor cells. Indeed, some radial glial cells along the brain ventricles express it as well and its expression is required for proper differentiation into ependymal cells and a subset of astrocytes [17] . A subset of progenitors also require FoxJ1 expression during the embryonic-to-postnatal transition in olfactory bulb neurogenesis [16] . These studies suggest that FoxJ1 is important not only in ciliogenesis, but also in cell fate specification of certain progenitor subtypes during development. However, its role during neurogenesis and gliogenesis in the developing spinal cord is still unknown.
Here, using three transgenic models, we report that FoxJ1 is transiently expressed not only by ependymal cells but also by earlier progenitors of other neural cell types during spinal cord development, including the progenitors of subsets of V1 and V2 interneurons and by progenitors of astrocytes of unknown origin. We also observed that FoxJ1 is involved in the regulation of progenitor cell proliferation during development, and maintenance of the ependymal cells stem cell potential from development to adulthood. In addition, we investigated the role of FoxJ1 in adult ependymal cells activated by spinal cord injury and found that FoxJ1 is required for their migration towards the lesion site. In summary, we propose that FoxJ1 has novel roles in the developing and adult spinal cord, beyond ciliogenesis, paving the way for further studies on its roles in spinal cord development and repair following SCI.
Materials and methods

Mice
All experiments were conducted in accordance with the guidelines of the Swedish Board of Agriculture (ethical permit N329/11, N217/ 14) and were approved by the Karolinska Institutet Animal Care Committee.
We used three mice lines in this study, including randomized grouped male and females (Fig. 2) . 1) Non-inducible FOXJ1::EGFP [27] (where the human FoxJ1 promoter driving EGFP expression were used for tissue collection at E10.5-E17.5 and P0-P10. 2) Tamoxifen-inducible FOXJ1-CreER T2 transgenic mice were crossed with Rosa26-YFP mice [23, 27] . 3) FoxJ1-KI-CreER T2 :Tomato mouse line for the study of FoxJ1 gene deletion effects, which was generated by crossing a knock-in mouse line with FoxJ1 deletion [26] with ROSA26-CAG-tdTomato reporter mice (The Jackson Laboratory stock #007908) for lineage tracing. The mouse lines were bred with C57Bl6/J so that the same genetic background allowed us to safely compare the different conditions. For tamoxifen-induced recombination in line 2 and 3, we injected the dams intraperitoneally with 60 mg/kg of body weight or gavaged mice 50 mg/kg daily for 2 days or 5 days in embryonic and postnatal stage, respectively. These animals were sacrificed one day after the last tamoxifen administration, as indicated on the Figures.
Tissue preparation and sectioning
At the end of the survival period, the adult animals (P60-P120) were deeply anesthetized with sodium pentobarbital (150 mg/kg body weight) and perfused transcardially with 0.1 M PBS, pH 7.4%, and 4% PFA in PBS, pH 7.4. Spinal cords from embryonic or early postnatal stages were dissected quickly on ice cold PBS after dams were sacrificed. Pups (P0-P10) were sacrificed by cervical dislocation and spinal cords were dissected on ice cold PBS. Dissected spinal cords were further post-fixed in 4% PFA in PBS at 4°C overnight and cryoprotected in 30% sucrose for at least 48 h. After embedding in Tissue-Tek OCT compound, the spinal cords were cut to 16 µm-thick sagittal or coronal sections using a cryostat. Sections were collected 1:12 accordingly to stereological principles and stored at − 20°C until further use.
Tissue processing
For experiments involving in situ hybridization (ISH), time-pregnant dams at embryonic day 11.5, 13.5 and 15.5 were overdosed with a mixture of ketamine and xylazine and transcardially perfused with a 0.9% saline solution followed by 4% paraformaldehyde (PFA), in borax buffer, pH 9.5. Embryos were collected, post-fixed for 2 days in PFA, and then placed in a 4% PFA-borax/10% sucrose solution until tissue processing. For neonatal mice, pups were killed by decapitation under ice anesthesia at post-natal day 10 (P10). Brains and spinal cords were dissected out and placed in fixative for 2 days, followed by transfer in a 4% PFA-borax/10% sucrose solution.
Frozen brains were mounted on a microtome and cut into 30-µm coronal sections from the olfactory bulb to the end of the medulla. Tissue sections were collected in a cold cryoprotectant solution and stored at − 20°C. All solutions were treated with diethylpyrocarbonate (DEPC) and sterilized to prevent RNA degradation. Spinal cords were embedded in OCT compound and then cut in 7 series of 14-µm-thick coronal sections using a cryostat (model CM3050S; Leica Biosystems). All spinal cord sections were collected directly onto X-tra Slides having a permanent positive charged surface (Leica Biosystems) and stored at − 20°C until use.
Surgical procedure and postoperative care
Dorsal funiculus transection was performed to mice at T10 level in the spinal cord. The surgical procedure and postoperative care was previously described in detail [20] . Briefly, the skin was incised at thoracic level and laminectomy performed to expose the spinal cord at T9-10 level. The spinal cord was transected with a micro knife (Fine Scientific Tools) in order to damage the dorsal finiculi. The central canal is left untouched by the procedure. The mice were checked daily for signs of distress and to monitor the physiological recovery of functions after injury.
Tissue preparation and sectioning
At the end of the survival period, the animals were deeply anesthetized with sodium pentobarbital (APL) (150 mg/kg body weight) and perfused transcardially with 0.1 M PBS, pH 7.4%, and 4% PFA in PBS, pH 7.4 (Life Technologies). Dissected spinal cords were further postfixed in 4% PFA in PBS at 4°C overnight and cryoprotected in 30% sucrose (Life Technologies) for at least 48 h. After embedding in TissueTek OCT compound (Sakura), the spinal cords were cut sagittally or coronally to 16-20 µm thickness. Sections were collected 1:10 accordingly to stereological principles and stored at − 80°C until further use.
Immunohistochemistry
Spinal cord sections were blocked with 10% normal donkey serum, 0.3% Triton X-100 in PBS for 1 h at room temperature. Primary and secondary antibodies were diluted in 2% BSA, 0.2% Triton X-100 in PBS. Primary antibodies were incubated at room temperature (RT) overnight and secondary antibodies were incubated for 1 h at RT. AlexaFluor conjugated secondary antibodies (Invitrogen) were used. Counterstaining was performed with DAPI (1:10,000) in PBS and sections were coverslipped with Vectashield mounting media. Full details of the primary antibodies used are reported in Table 1. 2.7. Neural stem cell cultures 2.7.1. Culture Animals were sacrificed for control culture or one week after SCI. Spinal cord cells were dissociated and neurosphere cultures were established as described before [20, 23] . After counting, cells isolated from one spinal cord were plated in T25 flasks. Primary neurospheres were harvested after 12 days in culture then were dissociated into single cells for passage or differentiation. Approximately 100,000 cells per animal were plated in T25 flasks for the next generation of neurospheres, and all the new neurospheres (second and third generation) were harvested after one week in culture. Dissociated primary neurospheres, approximately 70,000 cells/well, were plated in poly-L-lysinecoated chamber slides (Sigma) for differentiation with growth factorfree medium supplemented with 1% fetal bovine serum.
Immunocytochemistry
In order to assess the recombination rate after 12 days in vitro, approximately 100-200 recombined primary neurospheres were plated in poly-L-lysine-coated chamber slides for one day, followed by fixation with 4% PFA (20 min at room temperature) and immunocytochemistry for quantification of recombined neurospheres with either an anti-GFP or anti-TdTomato antibody. For differentiation assay, after 10 days in growth factor-free differentiation condition, immunocytochemistry was performed as described above. Full details of the primary antibodies used are reported in Table 1 .
Cell culture analysis
For the neurosphere proliferation assay, neurospheres were sampled from one culture dish in quadruplicate (250 ml per time) and the numbers of neurospheres were counted. The total number of neurospheres was calculated per total volume of media (30-35 ml per dish). For the neurosphere differentiation assay, we performed immunocytochemistry and quantified the marker expression by counting at least 6 fields of views selected in a randomized fashion (20× magnification) per well under fluorescence microscope. At least two wells for one marker per animal and condition were used for quantification of a minimum of 3 animals per group. The total number of cells was obtained counting DAPI + nuclei stained.
Image acquisition and tissue analysis
Confocal representative images of the spinal cords were acquired using the Zeiss LMS700 microscope set up (Zeiss). Quantification of the number of cells were performed using the Zeiss Apotome2 microscope set up (Zeiss). For the quantification, the regions along the rostralcaudal axis (cervical, thoracic and lumbar segments) were analyzed separately. In the same fashion, we quantified the grey matter, central canal, lateral white matter, dorsal white matter and floor plate. The tissue quantification was performed on at least 3 sections per segment and area. For each experimental group and marker, 3-9 animals were analyzed.
Experimental design and statistical analysis
We performed Student's T-test for comparing two groups and Student's T-test with Bonferroni's correction for more than two groups' comparisons by statistical analysis software Prism version 6.0. *P < 0.05, **P < 0.01, ***P < 0.001. For each experimental group and marker staining, 3-9 animals were analyzed.
Results
Spatiotemporal distribution of FoxJ1 lineage cells in the developing spinal cord
FoxJ1 transcription factor is specifically expressed in cells with motile cilia, including ependymal cells, which first appear at E15.5 in the developing spinal cord [20, 23, 3] . Surprisingly, we performed immunostaining for FoxJ1 protein, and found that E13 progenitor cells surrounding the ventricular zone express detectable levels of FoxJ1, several days prior to the appearance of the first ependymal cells at E15 [20] . These early FoxJ1+ cells included neuronal progenitors, as they are Nkx6.1 positive (Fig. 1B) .
To examine the progeny of the unexpected FoxJ1+ progenitors during development, we first used FOXJ1::EGFP transgenic mice ( Fig. 2A) , in which the human FoxJ1 promoter drives expression of enhanced green fluorescence protein that can be used as a short-term lineage tracing tool due to the relatively longer half-life of EGFP than FoxJ1 [27] . We confirmed that the progenitors expressing EGFP+ from the human FoxJ1 promoter do indeed express FoxJ1 protein ( Fig. 1C-F) . Subsets of EGFP+ FoxJ1 lineage cells were observed in the grey matter and floor plate during early development (E10.5-E14.5) and were found in the ventricular zone, floor plate, and ventral-lateral grey matter between E15.5 and E16.5, when ependymal cells first originate in the spinal cord [20] . EGFP + cells reached their highest number during late gestation (E17.5), when they also appeared in the dorsal white matter. Early postnatally (P2), the number of EGFP + cells decreased dramatically in all regions except for the central canal, which is then surrounded by mature ependymal cells. By P10, EGFP expression was strictly limited to central canal ependymal cells (Fig. 3A) . Quantification of EGFP+ cells confirmed these observations ( Fig. 3 B-E), and further revealed heterogeneity in the distribution of FoxJ1 lineage cells along the rostral-caudal axis of the spinal cord (cervical, thoracic and lumbar regions) ( Fig. 3B-E) . We summarize the spatiotemporal distribution of EGFP+ cells in the developing spinal cord of the FOX-J1::EGFP mice in the schematic (Fig. 3F ).
FoxJ1+ progenitors give rise to a subset of V1 and V2 interneurons during neurogenesis in the spinal cord
We next identified and quantified the cell types showing FoxJ1 promoter activity by immunofluorescence. During early development (E10.5-E13.5), EGFP signal was detected in interneurons expressing the pan-interneuron marker PAX2 (Fig. 4A-C) . Interneurons express subtype-specific markers in the medial-lateral homeodomains at the ventricle of the spinal cord during early development [1] . In FOXJ1::EGFP mice, we found that EGFP was absent from V0 interneurons (EVX1+), present in a limited number of V2 interneurons (Chx10+) (Fig. 4D-F) , and absent from the Olig2-expressing motor neuron (pMN) domain (Fig. 4G ). EGFP+ interneurons are already post-mitotic at E10.5 and in our experimental paradigm we observed that they did not express the proliferation marker Ki67 (Fig. 4H) . Thus, we conclude that most progeny of FoxJ1+ progenitors are V1 interneurons and a small subset are V2 interneurons.
FoxJ1+ progenitors give rise to subpopulations of dorsal and lateral astrocytes but not to oligodendrocytes during gliogenesis in the developing spinal cord
We further characterized the EGFP + cells in the dorsal and lateral areas of the spinal cord ( Fig. 5A ). Immunostaining showed that subsets of lateral and dorsal EGFP+ cells expressed astrocyte progenitor markers such as Vimentin, Sox9 and GFAP, ( Fig. 5B -E, N-Q, R, U), suggesting that they are derived from FoxJ1+ progenitors during the peak of the gliogenesis period (E15.5-E17.5). There is little knowledge about the developmental origin of spinal cord astrocytes, but previous studies have shown that astrocytes derived from lateral ventricular zone progenitors migrate horizontally towards the lateral white matter [15] . In agreement, we found a similar pattern of localization of EGFP+ astrocytes in the lateral white matter. As early as E13.5, a small subset (around 20%) of EGFP+ lateral astrocytes expressed Reelin and Pax6, and this co-expression increased later on (reaching around 40%) (Fig. 5 F-G, J-K, R-S). Interestingly, we found that another subset of EGFP+ astrocytes migrates from the dorsal apical domain of the ventricular zone to the dorsal funiculi of the spinal cord. EGFP+ lateral astrocytes appear at E13.5, while the EGFP+ dorsal astrocytes appear at E15.5. The dorsal population is smaller than the lateral astrocyte population (Fig. 5H-I , L-M, T-U). EGFP+ astrocytes were no longer detectable postnatally ( Fig. 5S-T) . EGFP+ cells did not co-stain with oligodendrocyte lineage markers such as Olig2 and Sox10 at late developmental stages E17.5 ( Fig. 5V-Y) . Together, our observations indicate that FoxJ1 is expressed in progenitors that later give rise to astrocytes, suggesting a potential role in the development and/or migration of specific astrocyte populations during embryogenesis.
3.1.3. FoxJ1+ progenitors give rise to ependymal cells and floor plate progenitors EGFP+ cells were observed surrounding the central canal and in the floor plate. Consistent with our previous study [20] , we found that the first EGFP+ ependymal cells appeared at E15.5 and highly expressed Vimentin and Sox9. The co-expression of these markers with GFP increased during development and reached almost 100% postnatally around the central canal (Fig. 6B,C,F,G) . On the other hand, EGFP+ at the floor plate cells displayed a high expression of progenitor markers, such as Vimentin, and an oscillating Sox9 expression pattern (Fig. 6D,E,H,I ). Interestingly, FoxJ1 lineage cells showed differing levels of proliferation in these regions of the developing spinal cord (Fig. 6J-M) .
Together, our data indicate that the FoxJ1+ progenitors give rise to multiple neural cell types during the neurogenic and gliogenic periods In the latter model (C), the CreER sequence is knocked into the FoxJ1 locus resulting in loss of expression of the interrupted FoxJ1 gene (knock in -KI) [26] .
of spinal cord development (summarized in Fig. 11 ), representing a potentially useful marker and tool for further study of the developmental origin and function of these cell types.
FoxJ1 is involved in progenitor proliferation in the developing spinal cord
To shed light on the functional roles of FoxJ1 during spinal cord development, we took advantage of two additional mouse lines. First, FOXJ1-CreER TdTomato reporter mice), the fate of cells in which at least one of the FoxJ1 alleles has been knocked out can be mapped [26] . Notably, immunostaining for the FoxJ1 protein showed that 100% of reporter-expressing ventricular zone/ central canal cells in all three mouse lines expressed FoxJ1, indicating that the human FOXJ1 promoter is not ectopically expressed in this area (Fig. 1C-D, Fig. 7B ).
Tamoxifen was administered to pregnant FoxJ1-KI-CreER T2 -TdTomato mice at either E10.5, E11.5, E13.5 or E15.5 for two days, and the embryos analyzed one day later. Immunostaining for endogenous FoxJ1 protein revealed that endogenous FoxJ1+ cells decreased dramatically in both the FoxJ1+/-and FoxJ1-/-offspring ( Fig. 7B-E) , indicating that FoxJ1 protein levels are not compensated in FoxJ1+/-cells by the remaining allele. Importantly, we observed that the distribution of the TdTomato+ FoxJ1 lineage cells was markedly altered, with recombined cells found only surrounding the central canal and floor plate, but not within the parenchyma (Fig. 7F-I) . In contrast, when this experiment was repeated using the FOXJ1-CreER T2 transgenic mouse line crossed with YFP reporter mice (FOXJ1-CreER T2 -YFP mice), in which both of the foxj1 alleles are intact, we found that tamoxifeninduced recombination closely mirrored what had been seen in FOX-J1::EGFP mice (Fig. 7F-G) . Since the genetic background and the tamoxifen treatments are identical between the FoxJ1-KI-CreER T2 -TdTomato and the FOXJ1-CreER T2 -YFP mouse lines used in this study, the more than five-fold difference observed in the number of recombined cells around the developing central canal appears to be due to differences in the behavior of the recombined cells (Fig. 7G-H (Fig. 7M) , suggesting that FoxJ1 is more implicated in proliferation of the earlier progenitor population. Thus, consistent with a previous study showing the involvement of FoxJ1 in progenitor proliferation and differentiation in the developing brain [16, 17] , we suggest that FoxJ1 is required for the proliferation and subsequent migration of at least a portion of FoxJ1+ progenitors during spinal cord development (Figs. 11-12 ).
FoxJ1 is required for maintaining the progenitor properties of spinal cord progenitors
It has been shown that FoxJ1 is required for ependymal cell differentiation in the developing brain [16, 17] . To further characterize the role of FoxJ1 during cell fate specification in the developing spinal cord, we quantified the ratio of various markers expressed by reporterpositive cells in both FOXJ1-CreER T2 -YFP and FoxJ1-KI-CreER T2 -TdTomato mice. This revealed that FoxJ1 deletion was associated with a statistically significant (more than three-fold) reduction in reporterpositive cells expressing the progenitor markers Sox9 and Vimentin around the central canal ( Fig. 8 A-C, F-G) . These FoxJ1-KI-CreER T2 -TdTomato cells showed a significant upregulation of the pan-interneuron marker Pax2 (Fig. 8 D and H) , but did not express astrocytic or oligodendrocytic markers (Fig. 8J-L) . Interestingly, despite upregulating Pax2, these cells did not co-express other neuronal marker such as Chx 10 (Fig. 8I) or the mature neuronal marker NeuN (Fig. 8E) . These results suggest that the deletion of FoxJ1 (one or both alleles) in -YFP mice respectively.
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progenitor cells leads these cells to prematurely exit from their proliferating phase, increases their neurogenic lineage specification, but is not sufficient to allow them to mature or terminally differentiate. Since previous studies indicate that at least a subpopulation of spinal cord ependymal cells retain stem/progenitor properties during adulthood ( [23] ; Barnabe-Heider et al. [3] ; [20] ), we further studied whether FoxJ1 gene deletion impacts these properties. Neurospheres are self-renewing and multipotent colonies that illustrate the presence 
of cells having stem/progenitor potential, and by P10, neurosphere formation from the spinal cord is restricted to FoxJ1-expressing cells [20] . After tamoxifen administration to dams of FoxJ1-KI-CreER T2 -
TdTomato and FOXJ1-CreER
T2
-YFP pups (P5-P9), pups were sacrificed at P10 and their spinal cords dissociated to generate primary neurosphere cultures (Fig. 9A) . Since homozygous FoxJ1 knockout leads to perinatal lethality [26] , only FoxJ1 +/-P10 pups could be obtained for this set of experiments. For each animal, we compared the ratio of neurospheres that were recombined in vitro to the ratio of central canal ependymal cells that were recombined in vivo. Consistent with our previous study [20] , this ratio was approximately equal in FOXJ1-CreER
-YFP mice, indicating that all recombined ependymal cells in vivo can give rise to recombined neurospheres. In the FoxJ1-KI-CreER T2 -TdTomato mice, however, this significantly declined (Fig. 9A-B) . Performing the same experiment with adult spinal cords, we observed similar results (Fig. 9C ). These data suggest that the loss of one copy gene of FoxJ1 diminishes the stem/progenitor potential of ependymal cells, but did not promote a new stem cell niche as all the neurospheres that survived during passages were still derived from FoxJ1 lineage (Fig. 9D-E) . Notably, examination of the total numbers of neurospheres (recombined and non-recombined) in WT (FoxJ1 -TdTomato mice (FoxJ1 +/-) at P10 supports that this diminished potential is unrelated to differences in recombination-related factors (Fig. 9F) . While WT and 
FOXJ1-CreER
T2
-YFP cultures generated equal numbers of total neurospheres, FoxJ1-KI-CreER T2 -TdTomato cultures yielded significantly fewer neurospheres, and this decrease was maintained during passaging.
Differentiation of the P10 and adult primary neurospheres obtained in the above experiments also revealed that the FoxJ1 +/-neurospheres generated from FoxJ1-KI-CreER T2 -TdTomato mice have an altered differentiation potential, producing significantly more neurons (Tuj1  + ) and fewer oligodendrocytes (CNPase + ) and astrocytes (Sox9 + ) compared to both WT and FOXJ1-CreER T2 -YFP mice. This is consistent with our in vivo quantifications that indicated that FoxJ1 deletion promotes cell fate specification towards the neurogenic lineage (Fig. 9 G-I) .
FoxJ1 is required for the recruitment of ependymal cells following spinal cord injury
Using the FOXJ1-CreER T2 lineage-tracing model, ependymal cells have been shown to be the source of neurosphere-forming stem cells in the adult spinal cord, and to respond robustly following spinal cord injury (SCI) [20, 23, 3, 32] . However, the contribution of ependymal cells to SCI has been recently challenged in a study using the FoxJ1-KICreER T2 -TdTomato lineage tracing model [30] . Since we observed here that both alleles of the FoxJ1 gene are required for the normal proliferation of progenitor cells, maintenance of stem/progenitor potential, and cell fate determination under normal physiological conditions (Figs. 7-9 ), we performed a side-by-side comparison of the ependymal -TdTomato mice received tamoxifen injections for 5 days to pre-label the central canal ependymal cells, and after an additional 7-day clearing period, were subjected to a mild dorsal funiculus lesion (Fig. 10A) . One week after SCI, ependymal cells were found to have migrated to the lesion site in FOXJ1-CreER TdTomato mice showed that, as in the absence of injury, the FoxJ1-KICreER T2 -TdTomato mice had a reduced proportion of recombined ependymal cells that were capable of neurosphere formation (Fig. 10  D) . Moreover, neurospheres from FoxJ1-KI-CreER T2 -TdTomato mice exhibited lower oligodendrocytic and higher neurogenic differentiation potential compared to WT and FOXJ1-CreER T2 -YFP cultures (Fig. 10 E-J ). These findings indicate that FoxJ1 is critical for normal ependymal self-renewal capacity, glial-neuronal differentiation potential, and migration under both physiological conditions and after SCI. Notably, FoxJ1-KI-CreER
T2
-TdTomato mice showed a striking defect in injury-induced spinal cord stem/progenitor activity that was independent of recombination-associated factors. When we quantified the total numbers of neurospheres (both recombined and non-recombined) in these mouse models, WT and FOXJ1-CreER T2 -YFP mice showed SCIinduced increases in neurosphere numbers while the FoxJ1-KI-CreER T2 -TdTomato mice with one less copy of FoxJ1 had significantly fewer neurospheres under both control and SCI conditions, and failed to exhibit any SCI-induced increase (Fig. 10 K) . We conclude that even though FoxJ1-KI-CreER T2 -TdTomato mice could be useful to lineage trace FoxJ1-expressing cells in other organs without causing a phenotype [26] , both copies of FoxJ1 are required for the full expression of stem cell properties in the spinal cord after SCI.
Discussion
In this study, we discovered several unexpected and unreported functions of FoxJ1 during spinal cord development and regeneration, using three transgenic models ( Fig. 2A-C) . We showed that FoxJ1 is not only expressed in ependymal cells, but is also transiently expressed in the progenitors of various cell types, including interneurons and astrocytes, which distribute to restricted zones of the developing spinal cord. FoxJ1 gene deletion revealed novel roles for FoxJ1 in proliferation and glial-neuronal cell fate determination of progenitor cells in the developing spinal cord. Furthermore, we found that loss of a single allele of the FoxJ1 gene was sufficient to compromise the maintenance of the stem cell potential of ependymal cells during spinal cord development, throughout adulthood and following SCI.
FoxJ1 has been widely studied for its role in ciliogenesis and has been regarded as one of the key transcription factors for cilium biogenesis [6] . In the adult spinal cord, FoxJ1 is specifically expressed by ependymal cells and is used as a specific marker for this cell population [23, 3] . We have previously reported that the first FoxJ1+ ependymal cells appear at E15.5 in the mouse spinal cord [20] .
Here we report that FoxJ1 is also transiently expressed in progenitors of other cell types in the developing spinal cord (summarized in Fig. 11 ). In the spinal cord, FoxJ1 progenitors appear earlier than ependymal cells, and give rise to V1 and a subset of V2 interneurons, and also subpopulations of astrocytes in the lateral white matter and the dorsal funiculus, as well as to ependymal cells around the central canal. Astrocytes constitute one of the most abundant cell populations in the spinal cord and are functionally heterogeneous [36] , however our current understanding of their developmental origin is quite limited. A very elegant study reported that astrocyte progenitor cells migrate horizontally from the ventricular zone to the lateral white matter [15] . In accordance with and complementary to these findings, we observed a subset of astrocytes derived from FoxJ1 progenitors that migrate horizontally from a lateral domain and dorsally from the apical domain of the ventricular zone to the ventrolateral white matter and the dorsal funiculus, respectively. We suggest that FoxJ1 might be used as a novel marker for future study of different neural cell subtypes in the developing spinal cord (Fig. 12) .
During development of the brain, FoxJ1 is involved in the migration and differentiation of progenitor cells towards the olfactory bulbs [16] . We observed that FoxJ1 might also be involved in migration of progenitor or stem cells in the developing spinal cord. Indeed, when we deleted only one allele of FoxJ1, we observed a very limited number of FoxJ1 +/-cells that were all restricted to the ventricular zone/central canal.
After SCI, the progeny of FoxJ1 +/-ependymal cells also failed to migrate to the injury site. Therefore, the absence of FoxJ1 appears to prevent migration and proliferation of some progenitor cells, without development of major physiological impairments, such as hydrocephalous or dysplasia. Moreover, it has been shown that FoxJ1 is required for embryonic-to-postnatal transition during olfactory bulb neurogenesis [16] . As Pax2 has been used as an immature neuron/ neuronal precursor marker [21, 29, 34] , while NeuN is a specific marker for mature neurons maturation [22, 24, 37] , we used these markers for immunostaining and found that deletion of FoxJ1 leads to a higher ratio of the PAX2+ interneurons from FoxJ1 lineage cells but decreased expression of the mature neuron marker NeuN. These results suggest that the deletion of FoxJ1 enhances the neurogenic potential of FoxJ1 + progenitors towards an interneuron fate, with reduced differentiation into fully mature neurons. Altogether, we suggest that FoxJ1 is involved in the regulation of proliferation and differentiation of different types of progenitor cells in the whole CNS. Interestingly, this is consistent with a recent study that showed similarly unexpected results after deletion of the transcription factor Prdm16, which is involved in neural stem cell maintenance and ciliogenesis. Prdm16 deletion at postnatal developmental stage results in no effect on ciliogenesis, but leads to downregulation of FoxJ1 expression and upregulation of genes associated with neuronal differentiation that interfere with ependymal cell differentiation potential [33] . FoxJ1 has not been considered a pivotal transcription factor in stem cells, but we observed that FoxJ1 is important to preserve the stem cell potential of spinal cord ependymal cells. Indeed, we cultured FoxJ1 +/+ and FoxJ1 +/-cells from P10 and adult mice, and in both ages and conditions, we observed that the loss of a single copy of the FoxJ1 gene leads to significantly reduced self-renewal of ependymal cells and fewer neurospheres. Previously, we described that the injury of the spinal cord enhances the self-renewal potential of spinal cord ependymal cells [20, 23, 3] . To test whether the injury could rescue the phenotype of the FoxJ1 +/-neurospheres, we put them in culture from the adult injured spinal cord, and again observed reduced self-renewal potential and diminished ability to generate neurospheres in culture, regardless of recombination, indicating a perturbed phenotype of stem and progenitor cell potential when one copy of FoxJ1 is lost. Thus, FoxJ1 is a key transcription factor for the maintenance of stem cell potential by spinal cord ependymal cells. Moreover, this is consistent with our in vivo data showing that the deletion of one FoxJ1 allele leads to failure of FoxJ1 + progenitor cell proliferation.
Our findings also shed light on a recent controversy regarding the contribution of ependymal cells to the glial response following SCI [30] . In that study, the authors used the FoxJ1-KI-CreER T2 -TdTomato mouse model as a lineage-tracing tool for FoxJ1-expressing ependymal cells. Here, we likewise observed that ependymal cells in the FoxJ1-KI model are largely unresponsive to SCI, in marked contrast to ependymal cells in the FOXJ1-CreER T2 -YFP model used here and in our previous studies [20, 23, 30, 3, 32] . Importantly, here we show that the deletion of even one allele of the FoxJ1 gene leads to substantial effects on progenitor cell specification, maintenance of stem cell properties, and -YFP neurospheres [20, 3] . Given its use of the endogenous FoxJ1 promoter, the FoxJ1-KI-CreER T2 -TdTomato mouse model has proven a useful tool to lineage trace FoxJ1-expressing cells in other organs [26] . Although we did not observe phenotypic changes in terms of breeding and behavior in the FoxJ1 +/-mice, our results suggest that at least in the spinal cord, this model is sub-optimal for fate mapping aimed at characterizing the behavior of normal ependymal cells in physiological or pathological conditions. In conclusion, we show that FoxJ1 is transiently expressed by progenitors of subsets of interneurons, astrocytes, ependymal, and floor plate cells of the developing spinal cord. Moreover, we report that FoxJ1 is not only involved in ciliogenesis, but also in proliferation and cell fate determination of distinct progenitor and stem cells and it is required for the maintenance of stem cell properties in ependymal cells during development, adulthood and after injury. Thus, our study expands our understanding of the role of FoxJ1 in the spinal cord. This paves the way for further studies on developmental and stem cell biology and the investigation of FoxJ1 as a potential therapeutic target.
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